This cross-departmental team of clinic nurses, nurse navigators, pharmacists and pharmacist technicians partnered to evaluate existing processes and leverage technology to improve compliance to oral oncolytic education, consent, and adherence standards. Readily available technology like Zoom and Cisco Jabber supported patient education, DocuSign allowed digital signatures, and Microsoft Teams facilitated ongoing review of oral oncolytic prescriptions. After this quality improvement initiative, oral oncolytic education and consent compliance increased from 60% on initial audit to 100%, with 90% occurring on same day the oral oncolytic was prescribed.
Oral oncolytics are often preferred by patients and clinicians for their comparative administration ease, convenience, flexibility, and reduced burden of care. The interdisciplinary team at Baptist Health, Miami Cancer Institute evaluated existing processes and leveraged technology to improve oral oncolytic compliance through education, consent, and adherence standards.
